2021 has been a strong year for equities where largecap benchmarks delivered 21-23 per cent returns to investors, and second-rung benchmarks delivering up to 60 per cent returns
Dealers were, however, not as optimistic about the rupee continuing with the same momentum in the New Year, with many citing elevated crude oil prices and India’s widening monthly trade deficits as red flags.
“We are very bullish for 2022. January and February will be very good for the market.â€
The index closed at 17,354.05, up 150.10 points or 0.87 per cent
The Nifty Pharma index closed 0.62 per cent up at 14223.0.
The current directionless price action with a possibility of further pressure to the downside has introduced heavy uncertainty to the digital asset market
After a flat start on the bourses, shares of CMS Info Systems witnessed strong demand, surging 19 per cent to scale an intraday high of Rs 260 per share. The scrip had initially listed at 220.2 apiece, a premium of merely two per cent over its issue price of Rs 216 on NSE. It listed a Rs 218.5 on BSE. About 23 lakh shares had changed hands on the bourse by 11.45 am.
"In 2020-21, TCIL achieved standalone revenue and profit-after-tax of Rs 17,492.90 million and Rs 527.70 million respectively," the release said.
High vehicle prices and impending launches of several electric models are likely to have affected demand
“The catch-up to value has happened over the last two years but that said, we are very positive that this will again be a positive return year for the third year in succession.â€
Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.